AGIO
Price
$30.94
Change
+$1.25 (+4.21%)
Updated
May 1 closing price
Capitalization
1.79B
90 days until earnings call
CRNX
Price
$33.52
Change
+$0.13 (+0.39%)
Updated
May 1 closing price
Capitalization
3.14B
6 days until earnings call
Ad is loading...

AGIO vs CRNX

Header iconAGIO vs CRNX Comparison
Open Charts AGIO vs CRNXBanner chart's image
Agios Pharmaceuticals
Price$30.94
Change+$1.25 (+4.21%)
Volume$597.5K
Capitalization1.79B
Crinetics Pharmaceuticals
Price$33.52
Change+$0.13 (+0.39%)
Volume$652.9K
Capitalization3.14B
AGIO vs CRNX Comparison Chart
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. CRNX commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Buy and CRNX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (AGIO: $29.69 vs. CRNX: $33.39)
Brand notoriety: AGIO and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 101% vs. CRNX: 61%
Market capitalization -- AGIO: $1.79B vs. CRNX: $3.14B
AGIO [@Biotechnology] is valued at $1.79B. CRNX’s [@Biotechnology] market capitalization is $3.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, AGIO is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 5 TA indicator(s) are bullish while CRNX’s TA Score has 6 bullish TA indicator(s).

  • AGIO’s TA Score: 5 bullish, 3 bearish.
  • CRNX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than AGIO.

Price Growth

AGIO (@Biotechnology) experienced а +4.65% price change this week, while CRNX (@Biotechnology) price change was +3.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.96%. For the same industry, the average monthly price growth was +8.43%, and the average quarterly price growth was -7.58%.

Reported Earning Dates

AGIO is expected to report earnings on Jul 31, 2025.

CRNX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+2.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.14B) has a higher market cap than AGIO($1.79B). AGIO YTD gains are higher at: -9.647 vs. CRNX (-34.696). CRNX has higher annual earnings (EBITDA): -336.07M vs. AGIO (-420.08M). CRNX has more cash in the bank: 1.35B vs. AGIO (894M). CRNX has less debt than AGIO: CRNX (51.7M) vs AGIO (57M). AGIO has higher revenues than CRNX: AGIO (36.5M) vs CRNX (1.04M).
AGIOCRNXAGIO / CRNX
Capitalization1.79B3.14B57%
EBITDA-420.08M-336.07M125%
Gain YTD-9.647-34.69628%
P/E Ratio2.66N/A-
Revenue36.5M1.04M3,513%
Total Cash894M1.35B66%
Total Debt57M51.7M110%
FUNDAMENTALS RATINGS
AGIO vs CRNX: Fundamental Ratings
AGIO
CRNX
OUTLOOK RATING
1..100
239
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
90
Overvalued
PROFIT vs RISK RATING
1..100
10057
SMR RATING
1..100
1895
PRICE GROWTH RATING
1..100
7981
P/E GROWTH RATING
1..100
86100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGIO's Valuation (42) in the Biotechnology industry is somewhat better than the same rating for CRNX (90) in the Pharmaceuticals Major industry. This means that AGIO’s stock grew somewhat faster than CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (57) in the Pharmaceuticals Major industry is somewhat better than the same rating for AGIO (100) in the Biotechnology industry. This means that CRNX’s stock grew somewhat faster than AGIO’s over the last 12 months.

AGIO's SMR Rating (18) in the Biotechnology industry is significantly better than the same rating for CRNX (95) in the Pharmaceuticals Major industry. This means that AGIO’s stock grew significantly faster than CRNX’s over the last 12 months.

AGIO's Price Growth Rating (79) in the Biotechnology industry is in the same range as CRNX (81) in the Pharmaceuticals Major industry. This means that AGIO’s stock grew similarly to CRNX’s over the last 12 months.

AGIO's P/E Growth Rating (86) in the Biotechnology industry is in the same range as CRNX (100) in the Pharmaceuticals Major industry. This means that AGIO’s stock grew similarly to CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIOCRNX
RSI
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 29 days ago
76%
Bearish Trend 17 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.860.60
+2.20%
GameStop Corp
AAPL212.501.29
+0.61%
Apple
SPY554.540.22
+0.04%
SPDR® S&P 500® ETF
BTC.X94207.310000-77.476560
-0.08%
Bitcoin cryptocurrency
TSLA282.16-9.87
-3.38%
Tesla

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with INSM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then INSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
+2.03%
INSM - AGIO
45%
Loosely correlated
+0.84%
OLMA - AGIO
45%
Loosely correlated
+2.38%
CRNX - AGIO
42%
Loosely correlated
+0.24%
RVMD - AGIO
42%
Loosely correlated
-0.71%
NOXOF - AGIO
41%
Loosely correlated
N/A
More

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with TRDA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+0.24%
TRDA - CRNX
54%
Loosely correlated
+2.13%
DNLI - CRNX
53%
Loosely correlated
N/A
ARWR - CRNX
52%
Loosely correlated
+3.12%
RVMD - CRNX
52%
Loosely correlated
-0.71%
XNCR - CRNX
52%
Loosely correlated
+4.16%
More